About Coimbra Genomics
Coimbra Genomics is a company based in Cantanhede (Portugal) founded in 2013. It operates as a B2B. Coimbra Genomics has raised $595 thousand across 1 funding round from investors including Portugal Ventures. Coimbra Genomics operates in a competitive market with competitors including Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.
- Headquarter Cantanhede, Portugal
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$595 K (USD)
in 1 rounds
-
Latest Funding Round
$595 K (USD), Seed
Jul 01, 2013
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Coimbra Genomics
Coimbra Genomics has successfully raised a total of $595K through 1 strategic funding round. The most recent funding activity was a Seed round of $595 thousand completed in July 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Coimbra Genomics
Coimbra Genomics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Portugal Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage-agnostic investments in tech and life sciences sectors are pursued.
|
Locked | Locked | Locked |
Investor details for Coimbra Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Coimbra Genomics
Investment portfolio details for Coimbra Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Coimbra Genomics
Detailed financials for Coimbra Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Coimbra Genomics Comparisons
Peer comparison for Coimbra Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Coimbra Genomics
Coimbra Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
Developer of predictive informatics based platform for drug discovery
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
Detailed competitors of Coimbra Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Coimbra Genomics
Complete news archive for Coimbra Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Coimbra Genomics
Coimbra Genomics was founded in 2013.
Coimbra Genomics is headquartered in Cantanhede, Portugal. It is registered at Cantanhede, Coimbra, Portugal.
Coimbra Genomics is a funded company, having raised a total of $595K across 1 funding round to date.
Coimbra Genomics offers comprehensive precision medicine solutions for healthcare providers, focusing on providing healthcare solutions, advancing biotech innovations, focusing on genomic solutions, and precision medicine. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Coimbra Genomics's top competitors include Helix, Benchling and BioAge Labs.
Coimbra Genomics has 1 investor. Key investors include Portugal Ventures.